Bachem Holding AG (BANB) – Weekly Analysis

BANB

Bachem Holding AG – SWX

“Patience reduces risk more reliably than prediction.”

Weekly Share Price & Valuation Overview

Market Overview

Open

63.5000

High

63.8500

Low

62.7000

Trend

0.77015

Bachem Holding AG

Switzerland • SWX - SIX Swiss Exchange • BANB • Currency: CHF

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was incorporated in 1971 and is headquartered in Bubendorf, Switzerland.

Key strengths

Growth + profitability: double-digit revenue and profit margins.
Healthy operating margin (≥15%) indicates efficient core operations.
Double-digit profit margin (≥10%) supports robust bottom-line economics.
Revenue growth ≥10% indicates solid top-line momentum.
Earnings growth ≥10% supports improving profitability trajectory.

Potential weaknesses

Quick ratio <0.8 — tight near-term liquidity without inventory.
Negative free cash flow — operations may rely on external financing.

Scale & Structure Core size and share structure. TTM values unless noted. “Estimated” where reconciled from per-share × shares.

Market Cap Total equity value of the company (share price × shares outstanding).: CHF 4.77B
Enterprise Value Operating value: market cap + total debt − cash.: CHF 4.79B
Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.: CHF 677.93M
Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.: CHF 211.69M
EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.: CHF 199.73M
Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).: CHF 9.07
EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).: 1.79
Dividend Yield Annual dividend ÷ share price. Reconciled using dividend per share when available.: 1.34%
Shares Outstanding: 74.98M
Float Shares: 31.36M
Implied Shares Outstanding: 75.98M

Profitability & Efficiency TTM basis. “Reconciled” = numerator ÷ TTM revenue. Margins reflect latest TTM calculations.

Operating Margin (TTM) Strong Operating income ÷ revenue over the last twelve months (reconciled when possible).: 21.38%
EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).: 29.46%
Gross Margin (TTM) Reconciled Gross profit ÷ revenue over the last twelve months (reconciled when possible).: 31.23%
Profit Margin (TTM) Solid Net income ÷ revenue over the last twelve months (reconciled when possible).: 19.79%
ROA Return on assets: net income ÷ total assets.: 5.66%
ROE Return on equity: net income ÷ shareholder equity.: 10.07%

Growth Growth rates are YoY unless labeled QoQ.

Revenue Growth Strong Year-over-year revenue growth.: 30.20%
Earnings Growth (YoY) Strong Year-over-year earnings growth.: 39.60%
Earnings Growth (QoQ) Quarter-over-quarter earnings growth.: 38.60%

Liquidity & Solvency Balance-sheet health. Debt metrics shown as latest ratios; D/E is a ratio (not %).

Quick Ratio Liquid current assets ÷ current liabilities (ex-inventory).: 0.73
Debt to Equity Total debt ÷ shareholder equity; leverage.: 0.04
Total Cash Cash and equivalents.: CHF 29.14M
Total Debt Short + long-term interest-bearing debt.: CHF 60.87M
Net Debt Total debt − cash (negative = net cash).: CHF 31.73M
Debt / EBITDA Leverage relative to operating earnings; lower is safer.: 0.30

Cash Flow Shown only when internally consistent; margins are TTM.

Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).: CHF 143.92M
Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.: CHF -228.02M
OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).: 21.23%
FCF Margin (TTM) Free cash flow ÷ revenue (TTM).: -33.63%
Cash Conversion (OpCF/EBITDA): 0.72

Sharemaestro House View

Confidence: 2 Risk: 3 Composite Score: 3 Suggested Allocation: 5.00%

Structural Insights (experimental)

Ownership & Liquidity

Free Float 41.8%

Insiders 11.5%

Institutions 79.1%

Capital Structure

Potential Dilution

1.3%

Net Debt

CHF 31.73M

4.7% of revenue

Resilience Score 48

Methodology Notes

Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).

As of: 2025-09-09 12:44

Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.

Performance Edge: Signals that work. Valuations that spot mispricing early. A disciplined, data-driven methodology powered by machine learning. Sharemaestro helps high-net-worth investors, hedge funds, family offices, and institutions move sooner - and with conviction - when the market presents asymmetric opportunity.

Subscribe to Sharemaestro:

Please rotate your device

Menu

Weekly Share Price & Valuation Overview

Bachem Holding AG